Clinical Relevance

There is currently a pandemic of respiratory disease caused by a novel coronavirus (SARS-CoV-2) named “Coronavirus Disease 2019” (COVID-19). SARS-CoV-2 has demonstrated the capability to spread rapidly, leading to significant impacts on healthcare systems and causing societal disruption. The potential public health threat posed by COVID-19 is high, both to the United States and globally. To effectively respond to the COVID-19 outbreak, rapid detection of cases, appropriate clinical management, infection control, and implementation of community mitigation efforts are all critical. 

 

Under the FDA’s Emergency Use Authorization (EUA) for diagnostic testing, GeneIQ is committed to providing access to COVID-19 testing solutions with high-quality, high-throughput RT-PCR based assays. 

1-800-978-9805

972-942-0110

 

info@geneiqlab.com
 

3716 STANDRIDGE DR SUITE 204

THE COLONY, TEXAS 75056

CLIA #45D2181504

©2021 GENE IQ LAB. All Rights Reserved.